Theravance Biopharma
Price & Volume
Stats
See more52W Range | $9.10-$21.03 |
Market Cap | $843.9M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $109.7M |
Revenue Growth (YoY) | 15% |
Gross Profit (12 Mos) | $77.9M |
Diluted EPS | $2.23 |
News
See moreYahoo Finance • last month
Laughing Water Capital’s New Position: Theravance Biopharma, Inc. (TBPH)
Yahoo Finance • 2 months ago
Small-cap healthcare stocks with A+ grade EPS revisions ahead of earnings
Yahoo Finance • 2 months ago
TBPH Investors Have Opportunity to Join Theravance Biopharma, Inc. Fraud Investigation with the Schall Law Firm
Yahoo Finance • 3 months ago
Theravance drops rare disease drug after late-stage trial setback
About
CEO | Mr. Rick E. Winningham M.B.A. |
CFO | Mr. Aziz Sawaf C.F.A. |
Address | 901 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 90 |